Australia markets open in 8 hours 12 minutes

Annovis Bio, Inc. (ANVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.03-1.25 (-17.16%)
As of 11:47AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 80.24M
Enterprise value 74.48M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)19.68
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.65

Trading information

Stock price history

Beta (5Y monthly) 1.59
52-week change 3-47.36%
S&P500 52-week change 324.19%
52-week high 322.49
52-week low 35.23
50-day moving average 310.54
200-day moving average 310.67

Share statistics

Avg vol (3-month) 3388.82k
Avg vol (10-day) 31.29M
Shares outstanding 511.02M
Implied shares outstanding 627.24M
Float 88.14M
% held by insiders 124.59%
% held by institutions 111.45%
Shares short (15 Apr 2024) 41.45M
Short ratio (15 Apr 2024) 45.12
Short % of float (15 Apr 2024) 417.40%
Short % of shares outstanding (15 Apr 2024) 413.19%
Shares short (prior month 15 Mar 2024) 41.35M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-121.77%
Return on equity (ttm)-546.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-56.2M
Diluted EPS (ttm)-6.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.75M
Total cash per share (mrq)0.52
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.39
Book value per share (mrq)-0.74

Cash flow statement

Operating cash flow (ttm)-39.97M
Levered free cash flow (ttm)-23.75M